Peter Feinberg - 30 Sep 2025 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Issuer symbol
IMRX
Transactions as of
30 Sep 2025
Net transactions value
+$52,730
Form type
4
Filing time
01 Oct 2025, 08:59:40 UTC
Previous filing
30 Sep 2025
Next filing
07 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feinberg Peter Director 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE /s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg 01 Oct 2025 0001870076

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $52,730 +7,500 +5.3% $7.03 149,266 30 Sep 2025 Direct F1
holding IMRX Class A Common Stock 392,242 30 Sep 2025 General Partner of PF Associates L.P.
holding IMRX Class A Common Stock 476,615 30 Sep 2025 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115,441 30 Sep 2025 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $7.0049 to $7.055. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.